 |
PDBsum entry 1w2r
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
1w2r
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Solution structure of the complex between cr2 scr 1-2 and c3d of human complement: an x-Ray scattering and sedimentation modelling study.
|
 |
|
Authors
|
 |
H.E.Gilbert,
J.T.Eaton,
J.P.Hannan,
V.M.Holers,
S.J.Perkins.
|
 |
|
Ref.
|
 |
J Mol Biol, 2005,
346,
859-873.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Complement receptor type 2 (CR2, CD21) forms a tight complex with C3d, a
fragment of C3, the major complement component. Previous crystal structures of
the C3d-CR2 SCR 1-2 complex and free CR2 SCR 1-2 showed that the two SCR domains
of CR2 form contact with each other in a closed V-shaped structure. SCR 1 and
SCR 2 are connected by an unusually long eight-residue linker peptide.
Medium-resolution solution structures for CR2 SCR 1-2, C3d, and their complex
were determined by X-ray scattering and analytical ultracentrifugation. CR2 SCR
1-2 is monomeric. For CR2 SCR 1-2, its radius of gyration R(G) of 2.12(+/-0.05)
nm, its maximum length of 10nm and its sedimentation coefficient s20,w(o) of
1.40(+/-0.03) S do not agree with those calculated from the crystal structures,
and instead suggest an open structure. Computer modelling of the CR2 SCR1-2
solution structure was based on the structural randomisation of the
eight-residue linker peptide joining SCR 1 and SCR 2 to give 9950 trial models.
Comparisons with the X-ray scattering curve indicated that the most favoured
arrangements for the two SCR domains corresponded to an open V-shaped structure
with no contacts between the SCR domains. For C3d, X-ray scattering and
sedimentation velocity experiments showed that it exists as a monomer-dimer
equilibrium with a dissociation constant of 40 microM. The X-ray scattering
curve for monomeric C3d gave an R(G) value of 1.95 nm, and this together with
its s20,w(o) value of 3.17 S gave good agreement with the monomeric C3d crystal
structure. Modelling of the C3d dimer gave good agreements with its scattering
and ultracentrifugation parameters. For the complex, scattering and
ultracentrifugation experiments showed that there was no dimerisation,
indicating that the C3d dimerisation site was located close to the CR2 SCR 1-2
binding site. The R(G) value of 2.44(+/-0.1) nm, its length of 9 nm and its
s20,w(o) value of 3.45(+/-0.01) S showed that its structure was not much more
elongated than that of C3d. Calculations with 9950 models of CR2 SCR 1-2 bound
to C3d through SCR 2 showed that SCR 1 formed an open V-shaped structure with
SCR 2 and was capable of interacting with the surface of C3d. We conclude that
the open V-shaped structures formed by CR2 SCR 1-2, both when free and when
bound to C3d, are optimal for the formation of a tight two-domain interaction
with its ligand C3d.
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Schematic diagrams of the CR2 SCR 1-2/C3d complex
to show three alternative models for the complex comprising
either (a) a compact V-shaped SCR structure, (b) an extended SCR
structure, or (c) a folded-back SCR structure. The domains are
drawn approximately to scale. The two SCR domains are joined by
an eight residue linker (8) with their N terminus and C terminus
denoted by N and C, respectively. Two potential N-linked
glycosylation sites at Asn101 and Asn107 are shown by Y symbols.
In this study, CR2 SCR 1-2 is deglycosylated, and only single
GlcNAc residues are found at these two sites.
|
 |
Figure 4.
Figure 4. X-ray distance distribution functions P(r) for
CR2 SCR 1-2, C3d, and their complex. The maximum M of each P(r)
curve shows the most frequently occurring distance within each
molecule. The maximum dimension is denoted by L. (a) For CR2 SCR
1-2, M occurs at 2.1 nm and L at 10 nm. (b) For C3d, five
different sample concentrations are shown at 0.5 mg ml -1 (red),
0.8 mg ml -1 (orange), 1.1 mg ml -1 (green), 2.1 mg ml -1
(blue), and 3.73 mg ml -1 (pink) from bottom to top. The three
broken lines represent P(r) curves whose intensities have been
increased by factors of 8.5 (0.5 mg ml -1), 7.0 (0.8 mg ml -1),
and 5.5 (1.1 mg ml -1) for clarity. Peak M[1] corresponds to
monomeric C3d and peak M[2] corresponds to its dimer. (c) For
the complex, M occurs at 3.0 nm and L at 9 nm.
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2005,
346,
859-873)
copyright 2005.
|
 |
|
|
|
|
|
Headers
|
 |
|
|
|
 |